Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus
Abingdon Health PLC (ABDX.L) Launch of Semi-Quantitative Accessory to AbC-19T
To help indicate the strength of antibody response and possible immunity
Avacta Group PLC (AVCT.L) Update on COVID-19 Test Development with Adeptrix
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
Avacta Group PLC (AVCT.L) Avacta/Cytiva Partnership Ahead of Schedule
Several highly specific Affimer reagents for a COVID-19 antigen rapid test successfully generated